SCHEMBL25845234

SCHEMBL25845234

COC(=O)CC1(c2ccc(O)cc2)OCCO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESRRB O95718 1/20 0.38
MIF P14174 5/20 0.38
HDAC6 Q9UBN7 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HSP90AB1 P08238 1/20 0.34
TP53 P04637 1/20 0.33
SOAT1 P35610 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20926920 0.86 GAA (0.42) ALDH1A1LMNAMAPTHTTKMT2A
SCHEMBL16179274 0.75 MIF (0.38) ESRRBMIFHDAC6CA12CA1
SCHEMBL8537470 0.73 ALDH1A1 (0.40) ALDH1A1LMNAMAPTHTTKMT2A
SCHEMBL4790080 0.72 ALDH1A1 (0.49) MIFALDH1A1LMNAMAPTHTT
SCHEMBL6157178 0.71 ALDH1A1 (0.43) ESRRBALDH1A1LMNAMAPTHTT
SCHEMBL9337866 0.71 GAA (0.59) ALDH1A1LMNAKMT2AGAA
SCHEMBL2083953 0.70 CA12 (0.39) CA12CA2CA7CA9CA14
SCHEMBL4611767 0.69 LMNA (0.42) ESRRBALDH1A1LMNAMAPTHTT
SCHEMBL743102 0.68 MGAM (0.42) ALDH1A1KMT2AHSD17B10TP53GLA
SCHEMBL16179365 0.67 MIF (0.39) ESRRBMIFHDAC6CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339919-A1 BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICAL APPLICATION THEREOF AB Pharma Ltd. (CN) 2023-10-26 US disclosed
US-20230339919-A1 BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICAL APPLICATION THEREOF AB Pharma Ltd. (CN) 2023-10-26 US disclosed
EP-4212528-A1 BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUND AND MEDICAL APPLICATION THEREOF AB Pharma Ltd. (CN) 2023-07-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339919-A1 BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICAL APPLICATION THEREOF GPR55, GPR65, GPR4 ESRRB 339/4885MIF 4305/4885HDAC6 2217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.